Here’s what is the Price to Earnings Ratio (P/E Ratio) and 4 key ways investors can use it to their advantage!
What is the Price to Earnings Ratio or the P/E ratio? The P/E ratio is the most used multiple of…
Qantas (ASX:QAN) Soars 9% on FY25 Results as Revenue Hits A$23.8 Billion
Investors Reward Qantas as Recovery Turns Into Renewed Momentum Qantas (ASX:QAN) surged 9 percent today after unveiling its FY25 results,…
Why Telix (ASX:TLX) Fell 20% After FDA News – And What Investors Should Know
When expectations fall short, sentiment can shift in an instant. That is exactly what happened with Telix Pharmaceuticals (ASX: TLX)…
Inside Weebit Nano’s 333% Revenue Surge and the Future of ReRAM
Is This the Inflection Point Investors Have Been Waiting For? Weebit Nano (ASX:WBT) opened this morning with a 6% gain,…
NVIDIA (NASDAQ: NVDA) Q2 Results: The Numbers Behind Its Biggest Leap Yet
NVIDIA’s Blackwell Boom: The Chip Redefining the Future of AI and Investor Growth NVIDIA (NASDAQ: NVDA) once again surprised markets…
ReadyTech (ASX:RDY): Its tech peers are swimming but this stock is sinking! How can it turn around?
ReadyTech (ASX:RDY) has followed a different course to many other tech stocks on the ASX, holding firm as interest rates…
IPD Group (ASX:IPG): It’s still the best way on the ASX to gain exposure to electric vehicles and its cheap
If you thought all IPOs that listed during the pandemic turned out to be flops, you’d be wrong – because…
If the Albanese government shifts the tax burden from Gen Z to Boomers, these 4 ASX stocks could win and these 4 could lose
It seems the Albanese government is keen for Boomers to shoulder more of the tax burden than they are right…
Dominos Pizza Enterprises (ASX:DMP): FY25 was another year of the ship sinking further, but is there any hope for FY26?
Dominos Pizza Enterprises (ASX:DMP) is now less than 10% of what it was in mid-2021 – how can this be…
A year since joining Tabcorp, ex-AFL boss Gillon McLachlan improved the stock’s formerly dwindling odds
When we last wrote about Tabcorp (ASX: TAH) in June 2024, we said that,’ it had been through a dog…
Galidesivir has made Island Pharmaceuticals the ultimate ‘America First’ play for ASX investors!
Think of ‘America First’ ASX stocks and Island Pharmaceuticals (ASX:ILA) typically hasn’t come to mind, but its acquisition of Galidesivir…
WiseTech caps off a volatile FY25 with a post-results sell off, but what’s next
What a volatile FY25 it as for WiseTech. Just look at all that it went through: Richard White was going…
Nova Eye Medical (ASX:EYE) has been on a strong run, up 50% in one month. Is there more upside?
Nova Eye Medical (ASX:EYE) is no clinical stage medtech company, but has just an exciting 12 months ahead as if…
Here are 5 ASX biotechs expecting clinical trial results in the next few months!
Here are 5 ASX biotechs expecting clinical trial results in the next few months! Dimerix (ASX:DXB) Dimerix is in the…
Is an RBA Rate Cut in November Locked In? What It Could Mean for Housing, Banks, and the Dollar
The RBA has again hinted more rate cuts are on the way, with markets eyeing November—potentially a game-changer for households,…